Natarajan, Kshama <br/><br/>
Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)   
 - 409-16 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1522-8002 
<br/><br/><label>Standard No.: </label>10.1038/sj.neo.7900252  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Cell Division--drug effects<br/>Choline--metabolism<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Epithelial Cells--metabolism<br/>Female<br/>Glycerylphosphorylcholine--metabolism<br/>Humans<br/>Indomethacin--pharmacology<br/>Isoenzymes--metabolism<br/>Magnetic Resonance Spectroscopy<br/>Membrane Proteins<br/>Monomeric GTP-Binding Proteins--metabolism<br/>NM23 Nucleoside Diphosphate Kinases<br/>Nucleoside-Diphosphate Kinase<br/>Phosphorylcholine--metabolism<br/>Prostaglandin-Endoperoxide Synthases--metabolism<br/>Transcription Factors--metabolism<br/>Tumor Cells, Cultured